id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0283-0008,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-09-30T18:25:49Z,,0,0,090000648049ea96
FDA-2002-E-0283-0009,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-09-30T18:39:15Z,,0,0,090000648049ea99
FDA-2002-E-0283-0006,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-09-30T18:23:05Z,,0,0,090000648049ea90
FDA-2002-E-0283-0005,FDA,FDA-2002-E-0283,Application for Patent Term Extension from Novartis Corporation,Other,Application,2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-09-30T18:20:23Z,,0,0,090000648049ea7f
FDA-2002-E-0283-0007,FDA,FDA-2002-E-0283,Letter from the U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-10-16T23:56:40Z,,0,0,090000648049ea94
FDA-2002-E-0283-0010,FDA,FDA-2002-E-0283,Letter from Novartis to FDA DMB,Other,Letter(s),2009-02-25T05:00:00Z,2009,2,2009-02-25T05:00:00Z,,2025-10-16T23:58:39Z,,0,0,090000648049ea9d
FDA-2002-E-0283-0004,FDA,FDA-2002-E-0283,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA; Correction,Notice,Correction,2005-11-07T05:00:00Z,2005,11,,,2025-09-30T18:16:40Z,05-22012,0,0,090000648049eaa1
FDA-2002-E-0283-0003,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2005-10-26T04:00:00Z,2005,10,,,2025-09-30T18:12:54Z,,0,0,090000648049ea9f
FDA-2002-E-0283-0002,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-24T05:00:00Z,2003,11,,,2025-10-16T23:53:47Z,,0,0,090000648049ea9b
FDA-2002-E-0283-0001,FDA,FDA-2002-E-0283,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA,Notice,General Notice,2003-03-05T05:00:00Z,2003,3,,,2025-09-30T17:55:20Z,03-4691,0,0,090000648049ea26